Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07014540 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

StatusNot Yet Recruiting
PhasePhase 4
Started2025-06-20
View on ClinicalTrials.gov ↗
To explore the efficacy and safety of irinotecan liposome injection combined with 5-FU/LV in the treatment of advanced neuroendocrine carcinoma (NEC)
Trial Details
NCT Number NCT07014540
Lead Sponsor Beijing GoBroad Hospital
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions Neuroendocrine Carcinomas (NEC)
Enrollment 45 participants
Start Date 2025-06-20
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-11